Chemsworth Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 07-07-2024
- Paid Up Capital ₹ 5.00 M
as on 07-07-2024
- Company Age 49 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue 2.67%
(FY 2023)
- Profit -31.39%
(FY 2023)
- Ebitda -129.95%
(FY 2023)
- Net Worth 7.33%
(FY 2023)
- Total Assets -2.99%
(FY 2023)
About Chemsworth
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Shriram Chandak, Karan Bagaria, Neha Bagaria, and One other member serve as directors at the Company.
- CIN/LLPIN
U24111KA1975PTC002894
- Company No.
002894
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Oct 1975
- Date of AGM
05 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Na, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Chemsworth?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shriram Chandak  | Director | 01-Jan-1985 | Current |
| Karan Bagaria | Director | 20-Nov-2009 | Current |
| Neha Bagaria | Director | 01-Aug-2005 | Current |
| Kum Bagaria | Director | 04-Apr-2008 | Current |
Financial Performance and Corporate Structure Insights of Chemsworth.
Chemsworth Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.67% increase. The company also saw a substantial fall in profitability, with a 31.39% decrease in profit. The company's net worth moved up by a moderate rise of 7.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chemsworth?
In 2023, Chemsworth had a promoter holding of 98.98% and a public holding of 1.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kemwell Private LimitedActive 52 years 11 monthsShriram Chandak and Karan Bagaria are mutual person
Kemwell Biopharma Private LimitedActive 16 years 7 monthsShriram Chandak and Neha Bagaria are mutual person
- North East Gases Pvt LtdActive 53 years 3 months
Shriram Chandak and Karan Bagaria are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Chemsworth?
Unlock and access historical data on people associated with Chemsworth, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chemsworth, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chemsworth's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
